The groundbreaking treatment of the medication represents a major advance in the handling of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – GLP-1 and GIP – resulting in greater https://tirzepatidepeptide608339.snack-blog.com/42242823/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment